✦ LIBER ✦

RNAi for research and therapy

✍ Scribed by Michael A Goldman

Book ID: 120703586
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 55 KB
Volume: 5
Category: Article
ISSN: 1465-6906
DOI: 10.1186/gb-2004-5-9-342

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potentials for RNAi in sarcoma research

Potentials for RNAi in sarcoma research and therapy: Ewing’s sarcoma as a model

✍ Heinrich Kovar; Josef Ban; Sarka Pospisilova 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Harnessing RNAi nanomedicine for precisi

Harnessing RNAi nanomedicine for precision therapy

✍ Peer, Dan 📂 Article 📅 2014 🏛 River Publishers 🌐 English ⚖ 918 KB

T.O.1 RNAi therapy for LGMD1A

✍ Liu, J.; Wallace, L.M.; Garwick-Coppens, S.E.; Hauser, M.E.; Mendell, J.R.; Harp 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

RNAi-based nanomedicines for targeted pe

RNAi-based nanomedicines for targeted personalized therapy

✍ Ala Daka; Dan Peer 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 679 KB

Safety and Efficacy of RNAi Therapy for

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

✍ Coelho, Teresa; Adams, David; Silva, Ana; Lozeron, Pierre; Hawkins, Philip N.; M 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 680 KB

RNAi and related mechanisms and their po

✍ Reuven Agami 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Introduction of double-stranded RNAs into cells can suppress gene expression by mechanisms such as mRNA degradation or inhibition of translation. In mammalian cells, these two responses intersect, a feature that was recently used for the development of novel tools for stable and specific gene inacti